Esperion Therapeutics ESPR Unchanged at 313 RangeBound Trading 20260520 KNOT KNOP Q4 2025 Earnings Miss by Significant Key Takeaways Netflix Inc NFLX A Key Holding in Mark Cubans Investment Portfolio Soybean Rally Extends as Sharp Gains Hold at Midday Market Watchers Eye Supply Dynamics Maldives Cave Incident Poses Potential Challenges for Tourism Sector Citi Sets StreetHigh 287 Target on Nebius Stock Whats Driving the Optimism After Stellar Q1